Adagene Inc (ADAG)
2.27
-0.10
(-4.22%)
USD |
NASDAQ |
Nov 14, 16:00
2.27
0.00 (0.00%)
After-Hours: 18:39
Adagene Total Liabilities (Quarterly): 44.19M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 44.19M |
| December 31, 2023 | 45.17M |
| June 30, 2023 | 52.51M |
| December 31, 2022 | 69.31M |
| June 30, 2022 | 65.87M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.95M |
| June 30, 2021 | 31.64M |
| December 31, 2020 | 173.65M |
| September 30, 2020 | 13.61M |
| December 31, 2019 | 162.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.61M
Minimum
Sep 2020
173.65M
Maximum
Dec 2020
69.18M
Average
48.84M
Median
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.390B |
| CASI Pharmaceuticals Inc | 42.25M |
| Zai Lab Ltd | 283.19M |
| China SXT Pharmaceuticals Inc | 9.197M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.78M |
| Shareholders Equity (Quarterly) | 56.59M |